11th Annual World Drug Manufacturing Summit - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

11th Annual World Drug Manufacturing Summit

11th Annual World Drug Manufacturing Summit
26-28th November 2012
Venue: Swissôtel, Düsseldorf, Germany

The Annual World Drug Manufacturing Summit sources and presents leading global case studies from Pfizer, GSK, AstraZeneca, Baxter, Bayer and many more.

The Summit is packed full of real life pharma manufacturing case studies, allowing you to benchmark your business against ‘best in class’ and ensure that you have the tools you need to form a coherent and logical strategy.

Key issues include:

  • Lean deployment, Maintenance and Development
  • QbD Implementation
  • Quality Control & Management
  • Cost Reduction
  • Engineering principles, Facility Upgrade & Maintenance
  • Tech transfer & Scale-up
  • Control & Decision-making Software & Technology
  • Anti-counterfeiting & Serialization

If you have any questions about the new programme, would like to register your interest in speaking at WDM 2012, or would like to book your place please contact Richard Jones on +44 (0)20 7202 7690 or at Richard.jones@wtgevents.com. Please visit www.wdmsummit.com or to book now for the discounted price of £1,495 (usual price £1995 - £500 saving) visit www.wdmsummit.com/summer.


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans

Click here